H3K27ac-Activated lncRNA-DAPK1-IT1 Aggravated Oxidative Stress Damage Induced by Focal Cerebral Ischemia/Reperfusion via the miR-25-3p/HMGB1 Molecular Axis

分享:

简介:

论文中使用的产品/服务

询价

摘要

Ischemic stroke is a prevalent neurological disorder, characterized by elevated mortality and significant long-term disability. Oxidative stress damage is an important pathological process that occurs after brain ischemia/reperfusion (I/R), in which the long non-coding RNA death-associated protein kinase 1 intronic transcript 1 (DAPK1-IT1) is aberrantly expressed and participates in oxidative stress damage; however, its specific mechanisms of action remain unclear. DAPK1-IT1 and miR-25-3p expression was detected using qRT-PCR in the mouse neuroblastoma N2a cells that received middle cerebral artery occlusion/reperfusion and oxygen-glucose deprivation/reperfusion. Functional gain and loss experiments were performed to manipulate DAPK1-IT1, miR-25-3p, and HMGB1 expression. The role of DAPK1-IT1 was assessed both in vivo and in vitro using CCK-8, flow cytometry, and western blotting. The results showed that the levels of DAPK1-IT1, HMGB1, and oxidative stress damage markers were significantly increased, whereas miR-25-3p expression was significantly downregulated. The expression levels of DAPK1-IT1 were positively correlated with ROS production. DAPK1-IT1 and HMGB1 were identified as potential targets of miR-25-3p. Knockdown of DAPK1-IT1 and HMGB1, as well as overexpression of miR-25-3p, is indeed protective and contribute to reducing oxidative stress damage by activating the Nrf2/HO-1 signaling pathway. DAPK1-IT1 overexpression caused oxidative stress damage in N2a cells by downregulating miR-25-3p expression and upregulating HMGB1 expression. Mechanistically, DAPK1-IT1 upregulated HMGB1 expression by sponging miR-25-3p and mediating histone H3 lysine 27 acetylation in the promoter region through the cAMP response element-binding protein-binding protein (CBP). In summary, we found that H3K27 acetylation-induced lncRNA-DAPK1-IT1 promotes oxidative stress damage caused by I/R through the miR-25-3p/HMGB1 axis. These findings help to improve our understanding of ischemic stroke and provide new therapeutic avenues.

关于派真

作为一家专注于AAV 技术十余年,深耕基因治疗领域的CRO&CDMO,派真生物可提供从载体设计、构建到 AAV、慢病毒和 mRNA 服务的一站式解决方案。凭借深厚的技术实力、卓越的运营管理和高标准的服务交付,我们为全球客户提供一站式CMC解决方案,包括从早期概念验证、成药性评估到IITINDBLA的各个阶段。

 

凭借我们独立知识产权的π-alphaTM 293 细胞AAV高产技术平台,我们能将AAV产量提高多至10倍,每批次产量可达1×10¹⁷vg,以满足多样化的商业化和临床项目需求。此外,我们定制化的mRNA和脂质纳米颗粒(LNP)产品及服务覆盖药物和疫苗开发的各个阶段,从研发到符合GMP的生产,提供端到端的一站式解决方案。

下载

用户登录

还没账号? 请注册
手机验证码登录
账号密码登录
手机号码*
验证码*
忘记密码?

首次使用手机号登录将自动为您注册

登录即代表阅读并接受《注册协议》 《用户协议》

新用户注册

已有账号?
手机注册
邮箱注册
手机号码*
验证码*
机构名称*
客户类型*

重置密码

手机找回密码
邮箱找回密码
手机号码*
验证码*
设置新密码*
确认新密码*